Fact CheckerSign in

NCT06936007Completed

Hematological Manifestations in Systemic Lupus Erythematosus Patients

Hematological Manifestations in Systemic Lupus Erythematosus: A Retrospective Cross-sectional Study From a Tertiary Care Center in Nepal

Source: ClinicalTrials.gov · Last updated 20 Apr 2025

Brief summary (registry, in English)

The goal of this observational study is to evaluate hematological abnormalities among patients with systemic lupus erythematosus (SLE) admitted to a tertiary care center in Nepal. The main question it aims to answer is: \- What are the types and frequencies of hematological abnormalities seen in hospitalized SLE patients in Nepal? The study retrospectively reviews medical records of SLE patients admitted between April 2018 and March 2023 to collect data on hematologic parameters, demographic profiles, clinical manifestations.

Status (registry)
Completed
Study type
Observational
Enrollment
99 (actual)
First submitted
7 Apr 2025
Start date
1 Nov 2024
Primary completion date
30 Dec 2024
Lead sponsor
Patan Academy of Health Sciences
Diseases
Lupus (SLE)
NCT number
NCT06936007

What you commit to

  • Study type: Observational
  • Participants enrolled: 99
  • From 1 Nov 2024 to the primary completion date, 30 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Underlying hematological diseases or conditions: Patients who had hematological disease (e.g. hemophilia, leukemia, lymphoma) or conditions that could independently affect hematological parameters.

Other

  • Incomplete records

Who the study is looking for

  • All the patient diagnosed with systemic lupus erythematosus based on 2019 European League of Associations for Rheumatology and American College of Rheumatology (2019 EULAR/ACR) criteria.

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Patan Hospital
Coordinator of this site? Confirm its status
LalitpurNepalUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.